CD162 Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
A SLe (x) -type proteoglycan, which through high affinity, calcium-dependent interactions with E-, P- and L-selectins, mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in inflammation. Critical for the initial leukocyte capture.
Synonyms
CLA; CD162; PSGL1; PSGL-1; P-selectin glycoprotein ligand 1; Selectin P ligand; SELPLG
Gene ID
6404
Swiss Prot
Q14242
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human
Immunogen
251-350/412
Target
CD162
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human PSGL-1/CD162
Applications
WB, FCM
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), FCM (1:20-100)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
6404
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1341161-01 0.02 mg (E-Coli)
Recombinant Bradyrhizobium japonicum Non-canonical purine NTP pyrophosphatase (bll0673)
Ask
View Details MBS1341161-02 0.1 mg (E-Coli)
Recombinant Bradyrhizobium japonicum Non-canonical purine NTP pyrophosphatase (bll0673)
Ask
View Details MBS1341161-03 0.02 mg (Yeast)
Recombinant Bradyrhizobium japonicum Non-canonical purine NTP pyrophosphatase (bll0673)
Ask
View Details